Plan B Investigation May Get No HELP In Senate
This article was originally published in The Tan Sheet
FDA's handling of an emergency contraception switch may be less likely to come under investigation with new leadership on the Senate HELP committee
You may also be interested in...
Sen. Hillary Clinton (D-N.Y.) is calling for a hearing and separate GAO investigation into FDA's decision to deny OTC approval of Barr's Plan B (levenorgestrel) emergency contraceptive
The confirmation process for FDA Commissioner-nominee Jane Henney, MD, is in the hands of the Senate leadership after the Senate Labor & Human Resources Committee voted in favor of the nomination Sept. 23.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC